Effects of branched-chain amino acids on plasma amino acids in amyotrophic lateral sclerosis

• Published in: Amino acids Vol. 11; no. 1; pp. 37 - 42
• Main Authors: Gredal, O, Møller, S E
• Format: Journal Article
• Language: English
• Published: Austria 01.01.1996
• ISSN: 0939-4451; 1438-2199
• DOI: 10.1007/BF00805719

Although the cause of amyotrophic lateral sclerosis (ALS) remains unknown, biological findings suggest that the excitatory amino acid glutamate contributes to the pathogenesis of ALS. In previous studies of ALS, the therapeutic effect of the branched-chain amino acids (BCAAs) leucine, valine and isoleucine has been evaluated. The present study aimed at investigating the acute effect of BCAAs on plasma glutamate levels in ALS patients. Following two oral doses of BCAAs, significantly increased plasma levels were seen for valine (500%), isoleucine (1,377%) and leucine (927%), however the plasma level of glutamate was not affected. The plasma level of several other amino acids (tryptophan, tyrosine, phenylalanine and methionine) were found decreased after oral BCAAs, which may indicate a diminution in the rate of degradation of muscle protein and/or an increase in tissue disposal of amino acids.